Cresset is a company based in the United Kingdom, founded in 2002, that operates within the software industry, specifically focusing on healthcare software and computational chemistry tools. With a workforce of 51 to 200 employees, Cresset provides solutions that enhance drug discovery processes, particularly in the area of substance repurposing. Their published document discusses the advantages of repurposing existing pharmaceutical compounds for new medical uses, highlighting its potential for shorter development timelines and reduced costs compared to traditional drug discovery methods. The document emphasizes the importance of leveraging existing pharmacological knowledge and safety data when identifying commercially viable targets for drug repositioning. Cresset's expertise lies in combining pharmacological insights with computational tools to facilitate the identification of new therapeutic applications for established drugs, thereby aiming to improve patient access to treatments. The company’s focus on the intricacies of intellectual property in drug repurposing further illustrates its commitment to navigating the complexities of the pharmaceutical landscape.